Group 1 - The Hong Kong stock market's innovative drug sector has seen significant gains since the beginning of the year, with multiple indices rising over 100% [1] - Recently, the Hang Seng Pharmaceutical ETF (159892) has experienced a slight pullback from its recent highs, indicating a shift in market focus towards AI [1] - On September 25, the Hang Seng Pharmaceutical ETF briefly rose over 1%, with leading stocks such as Crystal Technology Holdings, BeiGene, and CanSino Biologics showing strong performance [1] Group 2 - Crystal Technology Holdings, a representative stock in the AI medical field, has shown continuous upward movement, rising for four consecutive days and achieving over 100% growth year-to-date [1] - Market opinions suggest that as supply continues to proliferate and iterate, many AI medical companies are still positioned relatively low, indicating potential for improvement in their core business performance [1] - The Hong Kong Stock Connect Medical ETF (520510) tracks the Hong Kong Stock Connect Medical Theme Index, holding stocks like WuXi Biologics, Alibaba Health, JD Health, and Crystal Technology Holdings, focusing on AI medical and CXO themes [1]
AI医疗火爆！晶泰控股连续上涨，恒生医药ETF交投活跃
Mei Ri Jing Ji Xin Wen·2025-09-25 02:42